Anika Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 2834 https://www.anikatherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics Inc

Hedge Funds Are Still Bullish On Anika Therapeutics, Inc. (ANIK) - Jun 23rd, 2020 3:50 pm
Anika Announces Planned CFO Transition - Jun 2nd, 2020 8:05 pm
Anika to Participate in 2020 UBS Virtual Global Healthcare Conference - May 12th, 2020 8:05 pm
Anika Therapeutics Inc (ANIK) Q1 2020 Earnings Call Transcript - May 9th, 2020 3:00 am
Anika (ANIK) Moves to Buy: Rationale Behind the Upgrade - May 8th, 2020 4:00 pm
Anika Reports First Quarter 2020 Financial Results - May 7th, 2020 8:05 pm
Does Anika Therapeutics, Inc. (NASDAQ:ANIK) Have A High Beta? - May 1st, 2020 10:34 am
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer - Apr 27th, 2020 12:30 pm
Anika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7 - Apr 23rd, 2020 8:05 pm
Anika Takes Actions to Strengthen Liquidity in Light of COVID-19 - Apr 8th, 2020 8:05 pm
3 Benjamin Graham-Style Stocks - Apr 2nd, 2020 4:45 pm
How Does Anika Therapeutics's (NASDAQ:ANIK) P/E Compare To Its Industry, After The Share Price Drop? - Mar 26th, 2020 10:12 am
Can You Imagine How Anika Therapeutics's (NASDAQ:ANIK) Shareholders Feel About The 29% Share Price Increase? - Mar 11th, 2020 11:51 am
Anika Appoints David Colleran as General Counsel - Mar 4th, 2020 1:30 pm
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion - Feb 21st, 2020 12:46 pm
Anika Reports Fourth Quarter and Full Year 2019 Financial Results - Feb 20th, 2020 9:05 pm